Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
MaxCyte Share News (MXCT)
MXCT Share
Price
MXCT Share
News
MXCT Share
Chat
MXCT Share
Trades63
MXCT
Live RNS
MXCT Share
Charts
MXCT Broker
Ratings
MXCT Directors
Deals
MXCT Financial
Diary
MXCT
Fundamentals
MXCT Short
Positions
MXCT
Media
MXCT Company
Research
MXCT Company
Timeline
- There is currently no data for MXCT
MaxCyte News
MaxCyte raises 2024 revenue guide again, ahead of final report
(Alliance News) - MaxCyte Inc on Monday raised its 2024 revenue guidance above initial expectations, and above the updated guide reported in December....
MaxCyte ups core revenue guidance for 2024 as eyes 2025 cost savings
(Alliance News) - MaxCyte Inc on Monday said the current year has been good for the company as it upgraded its core revenue guidance for 2024 and anti...
MaxCyte upgrades revenue guidance after operational review
(Sharecast News) - Cell engineering technology specialist MaxCyte announced upgraded revenue guidance on Monday, following an operational review under...
MaxCyte third-quarter profit falls amid surging costs
(Alliance News) - MaxCyte Inc on Thursday said profit fell in the third quarter despite revenue growth, as costs increase more than 80%.
MaxCyte appoints new chief commercial officer
(Sharecast News) - Cell engineering company MaxCyte announced the appointment of Ali Soleymannezhad as its new chief commercial officer on Thursday, e...
MaxCyte enters licence agreement with Kamau Therapeutics
(Sharecast News) - Cell engineering technology company MaxCyte announced a strategic platform licence agreement with Kamau Therapeutics, a clinical-st...
MaxCyte touts strategic platform license deal with Kamau Therapeutics
(Alliance News) - MaxCyte Inc on Monday celebrated the signing of a strategic platform license agreement with Kamau Therapeutics, a clinical-stage ste...
Follow the stocks
